Phosphodiesterase (PDE) Inhibitors Market Size

Phosphodiesterase (PDE) Inhibitors Market size was valued at USD 3.15 billion in 2023 and is expected to reach USD 6.8 billion by 2036, registering around 6.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of phosphodiesterase (PDE) inhibitors is assessed at USD 3.3 billion.

The global market is projected to register a significant rise on account of the escalating prevalence of erectile dysfunction by various factors such as hypertension, obesity, testosterone deficiency, diabetes mellitus, and consumption of certain substance abuse and medications can lead to erectile dysfunction. According to the World Health Organization (WHO), about 150 million people have been affected by erectile dysfunction and this is projected to reach 230 million by 2025. It is a common medical condition affecting about 15% of men each year. Moreover, increasing cases of chronic diseases such as stroke, chronic obstructive pulmonary disease, heart diseases, pre-diabetes, and diabetes are estimated to support the development of phosphodiesterase (PDE) inhibitors